207 related articles for article (PubMed ID: 23074476)
1. Intrathecal baclofen pump for spasticity: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(7):1-93. PubMed ID: 23074476
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
Hasnat MJ; Rice JE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury.
Nuttin B; Ivanhoe C; Albright L; Dimitrijevic M; Saltuari L
Neuromodulation; 1999 Apr; 2(2):120-32. PubMed ID: 22151115
[TBL] [Abstract][Full Text] [Related]
4. A benefit-risk assessment of baclofen in severe spinal spasticity.
Dario A; Tomei G
Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
Lewis KS; Mueller WM
Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
[TBL] [Abstract][Full Text] [Related]
6. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
[TBL] [Abstract][Full Text] [Related]
7. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity.
Ordia JI; Fischer E; Adamski E; Spatz EL
J Neurosurg; 1996 Sep; 85(3):452-7. PubMed ID: 8751632
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin.
Ordia JI; Fischer E; Adamski E; Chagnon KG; Spatz EL
Neuromodulation; 2002 Jan; 5(1):16-24. PubMed ID: 22151777
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for spasticity following spinal cord injury.
Taricco M; Adone R; Pagliacci C; Telaro E
Cochrane Database Syst Rev; 2000; 2000(2):CD001131. PubMed ID: 10796750
[TBL] [Abstract][Full Text] [Related]
11. Baclofen in the treatment of cerebral palsy.
Albright AL
J Child Neurol; 1996 Mar; 11(2):77-83. PubMed ID: 8881981
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal Versus Oral Baclofen: A Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue, and Quality of Life.
McCormick ZL; Chu SK; Binler D; Neudorf D; Mathur SN; Lee J; Marciniak C
PM R; 2016 Jun; 8(6):553-62. PubMed ID: 26498518
[TBL] [Abstract][Full Text] [Related]
13. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.
Ertzgaard P; Campo C; Calabrese A
J Rehabil Med; 2017 Mar; 49(3):193-203. PubMed ID: 28233010
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis.
Ochs G; Naumann C; Dimitrijevic M; Sindou M
Neuromodulation; 1999 Apr; 2(2):108-19. PubMed ID: 22151114
[TBL] [Abstract][Full Text] [Related]
16. Intraspinal drug therapy.
Paice JA; Magolan JM
Nurs Clin North Am; 1991 Jun; 26(2):477-98. PubMed ID: 2047293
[TBL] [Abstract][Full Text] [Related]
17. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal and Oral Baclofen Use in Adults With Spinal Cord Injury: A Systematic Review of Efficacy in Spasticity Reduction, Functional Changes, Dosing, and Adverse Events.
Dietz N; Wagers S; Harkema SJ; D'Amico JM
Arch Phys Med Rehabil; 2023 Jan; 104(1):119-131. PubMed ID: 35750207
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal baclofen for severe spinal spasticity.
Penn RD; Savoy SM; Corcos D; Latash M; Gottlieb G; Parke B; Kroin JS
N Engl J Med; 1989 Jun; 320(23):1517-21. PubMed ID: 2657424
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
